BioSpace News Archive

BioMidwest

Harrow Announces New $100 Million Secured Credit Facility with Oaktree

Harrow, a leading U.S. eyecare pharmaceutical company, announced that it has entered into a $100 million secured credit financing agreement with funds managed by Oaktree Capital Management, L.P.

March 28, 2023
·
4 min read
Business

Silence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and Development

Silence Therapeutics plc today announced the appointment of Steven Romano, MD, as incoming Chief Medical Officer and Head of Research and Development.

March 28, 2023
·
5 min read
Newron Presents Six-Month Interim Data From the First 100 Patients Randomized in Study 014/015 at the 31st European Congress of Psychiatry

Newron Pharmaceuticals S.p.A. presented two e-posters at today’s “Schizophrenia and other psychotic disorders” session at the 31st European Congress of Psychiatry, taking place at the Palais des Congrès in Paris, France.

March 28, 2023
·
6 min read
Business

PDS Biotech Provides Business Update and Reports Fourth-Quarter and Full-Year 2022 Financial Results

PDS Biotechnology Corporation (NASDAQ: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, today provided a business update and announced its financial results for the year ended December 31, 2022.

March 28, 2023
·
13 min read
Business

Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Vera Therapeutics, Inc. today reported its business highlights for the fourth quarter and financial results for the full year ended December 31, 2022.

March 28, 2023
·
9 min read
Business

Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases

Sonoma Biotherapeutics, Inc. and Regeneron Pharmaceuticals, Inc. today announced a collaboration to apply their scientific and clinical expertise and respective technology platforms to the discovery, development and commercialization of novel regulatory T cell (Treg) therapies for autoimmune diseases.

March 28, 2023
·
10 min read
Evaxion Announces Increased Focus and Fast-Tracking of its New AI Discovery to Patients

Evaxion Biotech A/S announces an increased focus on its strategy around its core AI capabilities allowing fast and de-risked development of its pipeline.

March 28, 2023
·
4 min read
Drug Development

Athira Pharma Presents Preclinical Data Supporting Therapeutic Potential of Fosgonimeton for Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2023 International Conference

Athira Pharma, Inc. presented preclinical data highlighting the potential therapeutic benefits of fosgonimeton at the AD/PD™ 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders.

March 28, 2023
·
5 min read
Pharm Country

Fujirebio expands its assay menu in the field of neurodegenerative diseases with the launch of the fully automated Lumipulse® G NfL CSF and Lumipulse® G NfL Blood tests

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio announced the availability of the Lumipulse G NfL CSF and Lumipulse G NfL Blood assays for the fully automated random-access LUMIPULSE® G immunoassay systems.

March 28, 2023
·
3 min read
Drug Development

EnteroBiotix Initiates Phase 2 study of microbiome drug EBX-102 in liver cirrhosis and hepatic encephalopathy

EnteroBiotix Limited announced the initiation of a multi-centre randomised double-blind placebo controlled Phase 2 clinical trial.

March 28, 2023
·
4 min read